Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3001
-0.0041 (-1.35%)
At close: Jun 6, 2025, 4:00 PM
0.3000
-0.0001 (-0.03%)
After-hours: Jun 6, 2025, 7:16 PM EDT

Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of $10.12 million. The enterprise value is -$9.43 million.

Market Cap 10.12M
Enterprise Value -9.43M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Co-Diagnostics has 33.71 million shares outstanding. The number of shares has increased by 4.93% in one year.

Current Share Class 33.71M
Shares Outstanding 33.71M
Shares Change (YoY) +4.93%
Shares Change (QoQ) +3.80%
Owned by Insiders (%) 7.81%
Owned by Institutions (%) 17.51%
Float 31.08M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.65
Forward PS 10.44
PB Ratio 0.21
P/TBV Ratio 0.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.04.

Current Ratio 4.43
Quick Ratio 4.02
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -56.80% and return on invested capital (ROIC) is -36.62%.

Return on Equity (ROE) -56.80%
Return on Assets (ROA) -33.82%
Return on Invested Capital (ROIC) -36.62%
Return on Capital Employed (ROCE) -77.10%
Revenue Per Employee $26,497
Profits Per Employee -$271,668
Employee Count 132
Asset Turnover 0.05
Inventory Turnover 0.60

Taxes

In the past 12 months, Co-Diagnostics has paid $46,608 in taxes.

Income Tax 46,608
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -70.86% in the last 52 weeks. The beta is 0.58, so Co-Diagnostics's price volatility has been lower than the market average.

Beta (5Y) 0.58
52-Week Price Change -70.86%
50-Day Moving Average 0.32
200-Day Moving Average 0.80
Relative Strength Index (RSI) 48.89
Average Volume (20 Days) 720,466

Short Selling Information

The latest short interest is 166,099, so 0.49% of the outstanding shares have been sold short.

Short Interest 166,099
Short Previous Month 139,008
Short % of Shares Out 0.49%
Short % of Float 0.53%
Short Ratio (days to cover) 0.57

Income Statement

In the last 12 months, Co-Diagnostics had revenue of $3.50 million and -$35.86 million in losses. Loss per share was -$1.17.

Revenue 3.50M
Gross Profit 2.71M
Operating Income -38.37M
Pretax Income -35.81M
Net Income -35.86M
EBITDA -37.05M
EBIT -38.37M
Loss Per Share -$1.17
Full Income Statement

Balance Sheet

The company has $21.48 million in cash and $1.93 million in debt, giving a net cash position of $19.55 million or $0.58 per share.

Cash & Cash Equivalents 21.48M
Total Debt 1.93M
Net Cash 19.55M
Net Cash Per Share $0.58
Equity (Book Value) 47.92M
Book Value Per Share 1.43
Working Capital 18.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.41 million and capital expenditures -$437,972, giving a free cash flow of -$29.85 million.

Operating Cash Flow -29.41M
Capital Expenditures -437,972
Free Cash Flow -29.85M
FCF Per Share -$0.89
Full Cash Flow Statement

Margins

Gross Margin 77.52%
Operating Margin -1,097.15%
Pretax Margin -1,023.95%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.93%
Shareholder Yield -4.93%
Earnings Yield -354.45%
FCF Yield -295.02%

Analyst Forecast

The average price target for Co-Diagnostics is $5.50, which is 1,732.72% higher than the current price. The consensus rating is "Buy".

Price Target $5.50
Price Target Difference 1,732.72%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 175.27%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Co-Diagnostics has an Altman Z-Score of -0.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.09
Piotroski F-Score 2